Nicholas L. Coch


  • Thursday, February 1, 2007
    On January 9, 2007, the Supreme Court issued its decision in MedImmune, Inc. v. Genentech, Inc., holding that a patent licensee (MedImmune in this case) has standing to sue for a declaratory judgment of invalidity, unenforceability or noninfringement of a licensor's (i.e., Genentech's) patent even if the licensee is still paying royalties (albeit under...